Parabilis Medicines, Inc. (PBLS) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Parabilis Medicines, Inc. (PBLS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $98.0M, listed on NASDAQ, employing roughly 145 people, carrying a beta of 0.00 to the broader market. Fog Pharmaceuticals, Inc. Led by Mathai Mammen, public since 2026-06-10.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for PBLS as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →